Subject matter expert consultant for drug metabolism pharmacokinetics [dmpk].
Active Purchase Order Awarded Last action
- Contract number
- 75N95025P00418
- Awardee
-
Pearson Pharma Partners UEI TJN3M3UNJF15
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $184,000
Award facts
- Opportunity
-
- Subject Matter Expert Consultant for Drug Metabolism Pharmacokinetics [DMPK] Solicitation · 75N95025Q00250 · Posted Aug 8, 2025
- Contract value 100% obligated
- $184,000.00 Current and potential, with all options
- Completion date 57% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Thousand Oaks, CA 91362, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $75,000 | |
| Exercise an Option | $22,500 | |
| Exercise an Option | $62,500 | |
| Original award | $24,000 |
About this award
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a purchase order to Pearson Pharma Partners, a small business, for $184,000 to provide subject matter expert consultant services in drug metabolism pharmacokinetics (DMPK) under a total small business set-aside, effective September 18, 2025.
This is a modification to exercise option year one. Performance occurs in Thousand Oaks, California, with an ultimate completion date of September 17, 2027. The contractor furnishes an executive-level DMPK consultant to support the NIH Blueprint Neurotherapeutics Network program, providing services including evaluation of pharmacokinetic study protocols, strategic planning for drug discovery programs, regulatory documentation assistance, and team collaboration through video conferences and site visits. The purchase order is priced on a labor-hour basis with estimated minimum annual hours of 20 and a not-to-exceed maximum of 800 optional hours. The originating solicitation (posted August 8, 2025; due August 22, 2025) required candidates with a minimum of 15 years of experience in pharmacokinetics and drug metabolism, preferably with nervous system drug development expertise.
Quick answers
Who was awarded contract 75N95025P00418?
75N95025P00418 was awarded to Pearson Pharma Partners by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2025.
How much is contract 75N95025P00418 worth?
The government has obligated $184,000 on 75N95025P00418.
Which agency awarded contract 75N95025P00418?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025P00418, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95025P00418 competed?
The extent of competition for 75N95025P00418 was competed under sap. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award